• Explore /
  • Poster
  • / Analysis of Kohne's prognostic index in <i>KRAS</i> wild-type patients with metastatic colorectal cancer (mCRC) treated with salvage-line cetuximab-based regimen: HGCSG0901.

Analysis of Kohne's prognostic index in KRAS wild-type patients with metastatic colorectal cancer (mCRC) treated with salvage-line cetuximab-based regimen: HGCSG0901.

Abstract Poster

Authors

null

Ayako Doi

Department of Medical Oncology, KKR Sapporo Medical Center Tonan Hospital, Sapporo, Japan

Ayako Doi , Satoshi Yuki , Yasushi Tsuji , Takahide Sasaki , Hiraku Fukushima , Kazuteru Hatanaka , Hirohito Naruse , Hiroyuki Okuda , Takaya Kusumi , Koshi Fujikawa , Yasuo Takahashi , Soh Saitoh , Shinya Kajiura , Ayumu Hosokawa , Yutaka Watanabe , Fumiyasu Yamamoto , Mineo Kudo , Nobuaki Akakura , Yuh Sakata , Yoshito Komatsu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 634)

DOI

10.1200/jco.2014.32.3_suppl.634

Abstract #

634

Poster Bd #

E25

Abstract Disclosures

Similar Posters

First Author: Daisuke Sakai

First Author: Arthur C. Houts

First Author: William Joseph Chapin

Poster

2023 ASCO Annual Meeting

<em>KRAS </em>G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen.

KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen.

First Author: Aaron Ciner